KATHY ORDONEZ
CIK 1222643 · Chief Commercial Officer · last filed 2026-06-04
KATHY ORDONEZ is a Chief Commercial Officer who has filed 55 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for PACB, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$11.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.51M
4
55
-$11.34M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PACB | Director | 403,037 | $1.31 | $528.0K | -$10.87M | 18 | 2026-06-04 |
| QDEL | Director | 2,896 | $14.13 | $40.9K | $0 | 5 | 2021-05-20 |
| DGX | SVP, Diagnostic Solutions | 9,569 | $203.06 | $1.94M | $0 | 9 | 2013-04-02 |
| Celera CORP (CRA) Delisted | CEO and Director | 0 | — | — | -$465.2K | 22 | 2011-05-12 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | PACB | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | PACB | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | PACB | Grant (A) | +22,821 | $0 | EDGAR |
| 2024-03-19 | PACB | Exer (M) | +361,621 | $1.04M | EDGAR |
| 2023-05-26 | PACB | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | PACB | Grant (A) | — | $0 | EDGAR |
| 2022-02-17 | PACB | Sell (S) | −3,280 | -$37.7K | EDGAR |
| 2021-06-21 | PACB | Grant (A) | — | $0 | EDGAR |
| 2021-05-20 | QDEL | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | QDEL | Exer (M) | +1,040 | $0 | EDGAR |